Drug Search Results
More Filters [+]

Amobarbital

Alternative Names: amobarbital
Latest Update: 2024-05-22
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: GABA Receptor Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Brazil | Canada | Germany | Greece | Ireland | New Zealand | Slovenia | Taiwan | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Amobarbital

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title